Molina Healthcare Files 8-K on Shareholder Votes

TL;DR

Molina Healthcare filed an 8-K on May 3rd regarding shareholder votes from May 1st.

AI Summary

Molina Healthcare, Inc. filed an 8-K on May 3, 2024, reporting on matters submitted to a vote of security holders as of May 1, 2024. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).

Why It Matters

This filing provides transparency regarding corporate governance and shareholder decisions at Molina Healthcare, which can influence investor confidence and company strategy.

Risk Assessment

Risk Level: low — This is a routine corporate filing detailing shareholder votes and company information, with no immediate financial or operational risks indicated.

Key Numbers

• 1-31719 — SEC File Number (Identifies the company's filing history with the SEC.)
• 13-4204626 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• MOLINA HEALTHCARE, INC. (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• May 1, 2024 (date) — Earliest event reported
• May 3, 2024 (date) — Filing date
• 200 Oceangate, Suite 100, Long Beach, California 90802 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 Par Value MOH New York Stock Exchange

Filing Documents

• moh-20240501.htm (8-K) — 41KB
• 0001179929-24-000091.txt ( ) — 163KB
• moh-20240501.xsd (EX-101.SCH) — 2KB
• moh-20240501_lab.xml (EX-101.LAB) — 21KB
• moh-20240501_pre.xml (EX-101.PRE) — 12KB
• moh-20240501_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On May 1, 2024, Molina Healthcare, Inc., a Delaware corporation (the "Company"), held its Annual Meeting of Stockholders (the "Annual Meeting"). As of the close of business on March 8, 2024 (the "Record Date"), a total of 58,583,802 shares of the Company's common stock (the "Common Stock") were issued and outstanding. At the Annual Meeting, holders of 51,263,601 shares of Common Stock, or 87.5% of shares outstanding on the Record Date, were represented in person or by proxy, constituting a quorum. With regard to Proposal No. 1, for the election of the nine directors named below to hold office until the 2025 annual meeting, the stockholders voted as follows: Director Votes For Votes Against Abstentions Broker Non-Votes Barbara L. Brasier 49,049,593 498,076 28,781 1,687,151 Daniel Cooperman 48,151,456 1,395,111 29,883 1,687,151 Stephen H. Lockhart 49,233,328 313,297 29,825 1,687,151 Steven J. Orlando 44,835,004 4,611,955 129,491 1,687,151 Ronna E. Romney 41,998,893 7,548,829 28,728 1,687,151 Richard M. Schapiro 49,233,693 313,155 29,602 1,687,151 Dale B. Wolf 43,917,350 5,531,828 127,272 1,687,151 Richard C. Zoretic 49,246,032 300,566 29,852 1,687,151 Joseph M. Zubretsky 48,434,373 1,110,461 31,616 1,687,151 With regard to Proposal No. 2, for the approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 46,266,687 3,277,670 32,093 1,687,151 With regard to Proposal No. 3, for the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 48,658,680 2,568,533 36,388 — With regard to Proposal No. 4, the shareholder proposal regarding simple majority voting, the stockholders voted as follows: Vo

View Full Filing

View this 8-K filing on SEC EDGAR